Study finds genomic differences between CLL an... - CLL Support
Study finds genomic differences between CLL and Richter's, multiple subtypes of the disease and the molecular pathways by which it emerges
You need to be a member of this community to see this post.
4 Replies
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
Leukaemia Care Updated Patient Information - Richter's Syndrome in Chronic Lymphocytic Leukaemia
Leukaemia Care is a UK charity so the support information is UK based. However the information...
Disease Flare During Temporary Interruption of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia ( CLL ) - Pseudo Richters
Several of us have reported our CLL symptoms have come roaring back after discontinuing...
CLL SOCIETY'S ASH POSTER on our Free second opinion program plus two important papers from ASCO
Hi,
Just back from a frenetic and fantastic ASH, but still have news to share from ASCO.
But first...
YABTKi or Yet Another BTK inhibitor - an A to Z list of Bruton's Tyrosine Kinase Inhibitors and Degraders following ibrutinib's success
I'll admit that YABTKi is not a recognised CLL related acronym, (acronym lists are here...
With a CLL diagnosis, knowing more about your immune system could save your life!
When we are diagnosed with CLL/SLL or the precursor MBL, we need to appreciate that we are immune...
Related Posts
- Newly diagnosed with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - CLL/SLL or just found us? This post is for you!
- Richter Transformation Survival in CLL Appears Better Among Treatment-Naive
BTK inhibitors for the treatment of CLL - the current state of play of 'brutinibs'- Phase I/II trial of IPH2201 checkpoint inhibitor in combination with ibrutinib opens for patients with relapsed or refractory CLL
Zanubrutinib vs. Ibrutinib Patient Power Video by Dr. Jennifer Brown MD PHD
